STEPHANIE BROWN: Open Payments
NPI 1639390487 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 22 payments from 6 companies in 2025. Trend: 2023 $296 · 2024 $381 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 7 | $511 |
| AstraZeneca Pharmaceuticals LP | 3 | $224 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $189 |
| Paratek Pharmaceuticals, Inc. | 5 | $155 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| Novo Nordisk Inc | 5 | $102 |
Products named: NEFFY, NUZYRA, Auvelity, BREZTRI, Ozempic, AIRSUPRA, XHANCE, Wegovy.
Industry payments across TX — which companies pay providers there.
